Exagamglogene autotemcel
| Brand name | Casgevy |
|---|---|
| Active ingredient | Exagamglogene autotemcel |
| Strength | 4-13 × 10^6 CELL/ML |
| Dosage form | Suspension |
| Route | Intravenous |
| Modality | Biologic |
| FDA approval | December 2023 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.